T&R Biofab Co 246710.KQ · KRW

Its shares trade on KOSDAQ under the ticker 246710.KQ. It has been listed since 28 November 2018. In the fiscal year to 31 December 2025, it reported revenue of ₩26.97bn and a net loss of ₩31.95bn. At that date it held total assets of ₩92.71bn and shareholders' equity of ₩26.07bn.

T&R Biofab Co., Ltd engages in the manufacture and sale of biomedical equipment. The company is headquartered in Siheung, Gyeonggi-Do. The company went IPO on 2018-11-28. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production and sale of three Dimensions (3D) biodegradable polymer printing system, bioinks, 3D organoid and 3D cell therapies, among others. The bioinks are sold under the name of deCelluid. The firm distributes its products within the domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Won Su YoonChief Executive Officer, Director
• Mr. Yeong Pil KimChief Financial Officer
• Mr. Ju Seong ShimChief Operating Officer, Vice President
• Mr. Jin Hyeong ShimChief Technology Officer, Director
• Mr. Song Wan JinChief Scientific Officer, Director
• Mr. Seung Gyo JungManaging Director
• Mr. Ju Hyeong LeeInternal Auditor
• Mr. Yeong Jun ParkAssistant Managing Director
• Mr. Heon Yeong GwonNon-Executive Independent Director
• Mr. Se Hyeok OhNon-Executive Independent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.